Abstract WMP27: Strategies to Mitigate Tenecteplase (TNK) Dosing Errors in Acute Ischemic Stroke

Marlies Meinhold,Theresa DiFranco,Patricia Hushen

DOI: https://doi.org/10.1161/str.55.suppl_1.wmp27

IF: 10.17

2024-02-01

Stroke

Abstract:Tenecteplase (TNK) is currently being used for IV thrombolysis in acute ischemic stroke. “Tenecteplase is the first thrombolytic that can be administered over five seconds in a single dose.” (Genetech, 2023). While this is a great advance for thromboembolic pathology, dosing errors can cause devastating patient harm including death. This off-label use can lead to dosing errors related to the TNK packaging, which only states dosing for myocardial infarction. The dosing for myocardial infarction is 0.5 mg/kg while the dosing for stroke is 0.25 mg/kg. (Bach, 2023; Campbell et al., 2018; Wang et al., 2023). While implementing TNK for acute ischemic stroke, discrepancies were also noted in the rounding of the TNK dose. Dosages were rounded to the onehundredth decimal point, and clear labeling on the package was not evident. The significance of underdosing or overdosing of TNK may not achieve the desired patient outcome and may increase the risk of complications such as hemorrhage, anaphylaxis, thromboembolism, arrhythmia, intracranial hemorrhage, extended hospitalizations, and death. (Bach, 2023) Education was created and disseminated to inform physicians and nursing of the appropriate dosing of TNK for acute ischemic stroke. A TNK dosing chart was included with the pre-existing stroke packets to reinforce learning. The TNK dosing chart was updated to round the TNK dose to the nearest tenth of a decimal, then one step further with the chart showing the dosage to weight ranges. Interdisciplinary collaboration occurred with informatics, physicians, pharmacy, and nursing to get order sets to match the rounding rules. Lastly, special labeling was created for the packaging of Tenecteplase TNK to include dosing for acute ischemic stroke. Since the implementation of this quality improvement project, both nursing and physicians are more aware of the correct dosing of TNK for acute ischemic stroke and myocardial infarction. Mitigating the problem of unclear TNK dosing has prevented dosing errors for acute ischemic stroke and myocardial infarction as well as the negative outcomes associated with a medication error involving a high-alert medication.

peripheral vascular disease,clinical neurology